Are you a Stanford student interested in ETL and MS&E 472? If so, check out our FAQ!

The Accelerating Pace of Biotech Innovation

George Scangos, Vir Biotechnology
With Jody Puglisi, Stanford School of Medicine

Vir Biotechnology president and CEO George Scangos paints a picture of the future of biotechnology, including a vision for building safe, ethical gene therapies for many common diseases. Furthermore, he adds, advances in genomics may also allow us to significantly improve the speed and safety of clinical trials for new drugs.